keyword
MENU ▼
Read by QxMD icon Read
search

ADHD guidelines

keyword
https://read.qxmd.com/read/30776284/-transition-of-adolescents-with-attention-deficit-hyperactivity-disorder-implications-for-treatment-of-adults
#1
José Martínez-Raga, María López-Cerveró
Attention deficit hyperactivity disorder (ADHD) is a chronic, complex and multifactorial neurodevelopmental disorder associated with high rates of concurrent psychiatric disorders, along with problems and complications on different areas of individual functioning. ADHD is not exclusively a childhood disorder, 40-60% persisting into adulthood with an estimated prevalence of 2.5-5%. Adolescence is a stage where great and continuous changes occur, associated with a lower adherence to treatment, a greater vulnerability to the emergence of academic problems, more risk-behaviors, the onset of substance use and higher rates of other comorbid disorders...
2019: Medicina
https://read.qxmd.com/read/30745695/clinical-practice-guidelines-for-the-assessment-and-management-of-attention-deficit-hyperactivity-disorder
#2
Ruchita Shah, Sandeep Grover, Ajit Avasthi
No abstract text is available yet for this article.
January 2019: Indian Journal of Psychiatry
https://read.qxmd.com/read/30738544/meta-review-network-meta-analyses-in-child-and-adolescent-psychiatry
#3
REVIEW
Samuele Cortese, Anneka Tomlinson, Andrea Cipriani
OBJECTIVE: Network meta-analyses (NMAs) are gaining traction as the preferred method for evidence synthesis of intervention studies. This review aimed to summarize the basics of NMAs and conduct a meta-review of available NMAs on the treatment of child and adolescent psychiatric disorders by appraising their quality. METHOD: PubMed (Medline), PsycInfo, Embase, Ovid Medline, and Web of Knowledge were systematically searched (last update January 9, 2018). The quality of each included NMA was appraised using the AMSTAR-2 tool and the PRISMA-NMA checklist, which includes specific items for NMAs...
February 2019: Journal of the American Academy of Child and Adolescent Psychiatry
https://read.qxmd.com/read/30720856/-adhd-across-the-lifespan-the-need-for-guidelines-for-assessment-and-treatment-of-neurodevelopmental-disorders-in-an-aging-population
#4
Lotta Borg Skoglund
ADHD is a prevalent, persistent and impairing psychiatric disorder, to a large degree explained by familial factors. As opposed to what was previously known, a substantial portion of children and adolescents diagnosed with ADHD will continue to experience impairing symptoms across their lifespan.  However, the knowledge about ADHD in older adults (65+) is scarce and research has primarily focused on children and middle-aged adults. This case report highlights the importance of recognizing ADHD across the life span and describes »Nils«, who for over 40 years has received stimulant treatment for ADHD...
January 31, 2019: Läkartidningen
https://read.qxmd.com/read/30693097/psychoeducational-groups-versus-waitlist-in-treatment-of-attention-deficit-hyperactivity-impulsivity-disorder-adhd-in-adults-a-protocol-for-a-pilot-randomized-waitlist-controlled-multicenter-trial
#5
J R Vaag, M L Lara-Cabrera, O Hjemdal, B Gjervan, T Torgersen
Background: Psychoeducation is included in the Norwegian national guidelines for treatment of adult ADHD. Despite some promising results for the treatment of other conditions and ADHD, little is known about the efficacy of such interventions. This paper presents a protocol for a pilot randomized controlled trial featuring a psychoeducational group program for patients with ADHD. The main objective of this pilot trial is to investigate adherence, feasibility, and preliminary efficacy of a ten-session psychoeducational group designed to address specific challenges faced by adults diagnosed with ADHD...
2019: Pilot and Feasibility Studies
https://read.qxmd.com/read/30681669/adhd-in-children-and-youth-part-1-etiology-diagnosis-and-comorbidity
#6
REVIEW
Stacey A Bélanger, Debbi Andrews, Clare Gray, Daphne Korczak
Attention-deficit hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder. Three position statements have been developed by the Canadian Paediatric Society, following systematic literature reviews. Statement objectives are to: 1) Summarize the current clinical evidence regarding ADHD,2) Establish a standard for ADHD care, and3) Assist Canadian clinicians in making well-informed, evidence-based decisions to enhance care of children and youth with this condition. Specific topics reviewed in Part 1, which focuses on diagnosis, include: prevalence, genetics, pathophysiology, differential diagnosis and comorbid psychiatric disorders and developmental disorders...
November 2018: Paediatrics & Child Health
https://read.qxmd.com/read/30681666/adhd-in-children-and-youth-part-3-assessment-and-treatment-with-comorbid-asd-id-or-prematurity
#7
REVIEW
Brenda Clark, Stacey A Bélanger
Attention-deficit hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder. Three position statements have been developed by the Canadian Paediatric Society, following systematic literature reviews. Statement objectives are to: 1) Summarize the current clinical evidence regarding ADHD,2) Establish a standard for ADHD care, and3) Assist Canadian clinicians in making well-informed, evidence-based decisions to enhance care of children and youth with this condition. Specific topics reviewed in Part 3, which focuses on associated autism spectrum disorder, intellectual disability, and prematurity, include the challenges of diagnostic assessment, common presentations, the role of genetics, and treatment, including the benefits of physical activity...
November 2018: Paediatrics & Child Health
https://read.qxmd.com/read/30681665/adhd-in-children-and-youth-part-2-treatment
#8
REVIEW
Mark E Feldman, Alice Charach, Stacey A Bélanger
Attention-deficit hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder. Three position statements have been developed by the Canadian Paediatric Society, following systematic literature reviews. Statement objectives are to: 1) Summarize the current clinical evidence regarding ADHD,2) Establish a standard for ADHD care, and3) Assist Canadian clinicians in making well-informed, evidence-based decisions to enhance care of children and youth with this condition. Specific topics reviewed in Part 2, which focuses on treatment, include: evidence and context for a range of clinical approaches, combining behavioural and pharmacological interventions to address impairment more effectively, the role of parent and teacher (or other caregiver) training, the use of stimulant and nonstimulant medications, with effects and risks, and dosing and monitoring protocols...
November 2018: Paediatrics & Child Health
https://read.qxmd.com/read/30651751/child-mental-illness-and-the-help-seeking-process-a-qualitative-study-among-parents-in-a-ugandan-community
#9
V Skylstad, A Akol, G Ndeezi, J Nalugya, K M Moland, J K Tumwine, I M S Engebretsen
Background: Child mental illness contributes significantly to the burden of disease worldwide, and many are left untreated due to factors on both the provider and user side. Recognising this, the Ugandan Ministry of Health recently released the Child and Adolescent Mental Health (CAMH) Policy Guidelines. However, for implementation to be successful the suggested policy changes must resonate with the service users. To better understand the sociocultural factors influencing parental mental help-seeking, we sought insights from parents in the Mbale district of eastern Uganda...
2019: Child and Adolescent Psychiatry and Mental Health
https://read.qxmd.com/read/30614886/the-psychopharmacology-algorithm-project-at-the-harvard-south-shore-program-an-update-on-unipolar-nonpsychotic-depression
#10
Christoforos Iraklis Giakoumatos, David Osser
BACKGROUND: The Psychopharmacology Algorithm Project at the Harvard South Shore Program presents evidence-based recommendations considering efficacy, tolerability, safety, and cost. Two previous algorithms for unipolar nonpsychotic depression were published in 1993 and 1998. New studies over the last 20 years suggest that another update is needed. METHODS: The references reviewed for the previous algorithms were reevaluated, and a new literature search was conducted to identify studies that would either support or alter the previous recommendations...
January 2019: Harvard Review of Psychiatry
https://read.qxmd.com/read/30531411/cardiovascular-effects-of-drugs-used-to-treat-attention-deficit-hyperactivity-disorder-part-2-impact-on-cardiovascular-events-and-recommendations-for-evaluation-and-monitoring
#11
Thomas B Fay, Martin A Alpert
A variety of psychostimulant and non-psychostimulant medications have proven to be successful in reducing inattention, impulsivity and hyperactivity in individuals with attention-deficit/hyperactivity disorder with (ADHD). Psychostimulants used to treat ADHD include methylphenidate and related drugs and various amphetamine preparations. Non-psychostimulant medications used to treat ADHD include atomoxetine and two alpha-2 adrenergic agonists; guanfacine extended-release and clonidine extended-release. The psychostimulants and atomoxetine have been shown, on average, to increase heart rate (HR) by 3-10 beats/min, systolic blood pressure by 3-8 mmHg, and diastolic BP by 2-14 mmHg...
December 7, 2018: Cardiology in Review
https://read.qxmd.com/read/30530806/updated-2018-nice-guideline-on-pharmacological-treatments-for-people-with-adhd-a-critical-look
#12
Erlend Faltinsen, Morris Zwi, Xavier Castells, Christian Gluud, Erik Simonsen, Ole Jakob Storebø
No abstract text is available yet for this article.
December 10, 2018: BMJ evidence-based medicine
https://read.qxmd.com/read/30511593/the-adult-adhd-quality-measures-initiative
#13
Stephen V Faraone, Michael J Silverstein, Kevin Antshel, Joseph Biederman, David W Goodman, Oren Mason, Andrew A Nierenberg, Anthony Rostain, Mark A Stein, Lenard A Adler
OBJECTIVE: Quality measures (QMs; also known as Quality Indicators) quantify health care processes, outcomes, patient perceptions, and organizational structure and/or systems that are relevant to the provision of high-quality health care. We describe the first phase of a project that has as its ultimate goal the creation and validation of QMs for tracking the screening, diagnosis, treatment, and clinical follow-up of adults with ADHD. This will fill an important gap in the field of Adult ADHD because QMs for adult ADHD do not exist...
December 4, 2018: Journal of Attention Disorders
https://read.qxmd.com/read/30477233/the-construction-and-validation-of-child-adolescent-and-parental-decision-aids-for-considering-methylphenidate-drug-holidays-in-adhd
#14
Kinda Ibrahim, Gina Randolph, Olivia Doran, Parastou Donyai
Guidelines recommend encouraging young people with attention deficit hyperactivity disorder (ADHD) who are taking medication long-term, to discuss their preferences for stopping or changing their treatment, including a discussion about 'drug holidays', with their doctor. Yet, to date, no written information has been available to empower children and adolescents with ADHD and their parents to make informed decisions about drug holidays. The aim of this study was to design and develop a suite of decision aids to help families decide if they want to take a drug holiday from methylphenidate...
November 24, 2018: Pharmacy (Basel, Switzerland)
https://read.qxmd.com/read/30444210/assessing-risk-of-neurodevelopmental-disorders-after-birth-with-oxytocin-a-systematic-review-and-meta-analysis
#15
Nicole N Lønfeldt, Frank C Verhulst, Katrine Strandberg-Larsen, Kerstin J Plessen, Eli R Lebowitz
Experts have raised concerns that oxytocin for labor induction and augmentation may have detrimental effects on the neurodevelopment of children. To investigate whether there is the reason for concern, we reviewed and evaluated the available evidence by searching databases with no language or date restrictions up to 9 September 2018. We included English-language studies reporting results on the association between perinatal oxytocin exposure and any cognitive impairment, psychiatric symptoms or disorders in childhood...
November 16, 2018: Psychological Medicine
https://read.qxmd.com/read/30373494/adherence-to-recommended-care-guidelines-in-the-treatment-of-preschool-age-medicaid-enrolled-children-with-a-diagnosis-of-adhd
#16
Alex Moran, Nicoleta Serban, Melissa L Danielson, Scott D Grosse, Steven P Cuffe
OBJECTIVE: Attention-deficit/hyperactivity disorder (ADHD) is the most common neurodevelopmental disorder of childhood. Clinical guidelines recommend behavior therapy as the first-line treatment for preschool-age children with ADHD. This study evaluated longitudinal patterns of services received by Medicaid-enrolled children ages 2 to 5 with ADHD in seven southeastern states (Alabama, Florida, Georgia, Louisiana, Mississippi, North Carolina, and South Carolina). METHODS: A discrete sequence clustering analysis was used with 2005-2012 Medicaid Analytic eXtract data to profile patient-level utilization for each state, with a focus on receipt of psychological services and medication...
October 30, 2018: Psychiatric Services: a Journal of the American Psychiatric Association
https://read.qxmd.com/read/30255748/does-diet-affect-the-symptoms-of-adhd
#17
Cesar Cagigal, Tania Silva, Mariana Jesus, Carla Silva
INTRODUCTION: Attention deficit hyperactivity disorder (ADHD) is the most common psychiatric diagnosis in childhood and adolescence, with an estimated worldwide-pooled prevalence of 5,29%. The type of treatment depends on several factors. Psychopharmacological treatment entails undesirable side effects, with unclear long-term benefits, which has led the scientific community to investigate other therapeutic approaches, such as dietary interventions. METHODS: The authors conducted a classical review on the current treatment recommended in individuals with ADHD diagnosis, their dietary patterns, as well as dietary factors possibly implicated in the etiology and treatment of this disorder...
September 25, 2018: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/30232561/predictive-utility-of-childhood-diagnosis-of-icd-10-hyperkinetic-disorder-adult-outcomes-in-the-mta-and-effect-of-comorbidity
#18
L Eugene Arnold, Arunima Roy, Eric Taylor, Lily Hechtman, Margaret Sibley, James M Swanson, John T Mitchell, Brooke S G Molina, Luis A Rohde
Diagnostic guidelines differ between DSM attention-deficit/hyperactivity disorder (ADHD) and ICD hyperkinetic disorder (HKD). Only 145 of 579 children age 7-9 in the Multimodal Treatment Study of ADHD (the MTA) with combined-type DSM-IV ADHD met criteria for ICD-10 HKD, because major internalizing comorbidities and more stringent symptom count/pervasiveness requirements excluded most. The 145 HKD had significantly better 14-month medication response than the rest. We explored whether HKD had greater adult symptom persistence and/or impairment than other ADHD...
September 19, 2018: European Child & Adolescent Psychiatry
https://read.qxmd.com/read/30220514/trends-in-attention-deficit-hyperactivity-disorder-medication-use-a-retrospective-observational-study-using-population-based-databases
#19
Sudha R Raman, Kenneth K C Man, Shahram Bahmanyar, Anick Berard, Scott Bilder, Takoua Boukhris, Greta Bushnell, Stephen Crystal, Kari Furu, Yea-Huei KaoYang, Øystein Karlstad, Helle Kieler, Kiyoshi Kubota, Edward Chia-Cheng Lai, Jaana E Martikainen, Géric Maura, Nicholas Moore, Dolores Montero, Hidefumi Nakamura, Anke Neumann, Virginia Pate, Anton Pottegård, Nicole L Pratt, Elizabeth E Roughead, Diego Macias Saint-Gerons, Til Stürmer, Chien-Chou Su, Helga Zoega, Miriam C J M Sturkenbroom, Esther W Chan, David Coghill, Patrick Ip, Ian C K Wong
BACKGROUND: The use of medications to treat attention deficit hyperactivity disorder (ADHD) has increased, but the prevalence of ADHD medication use across different world regions is not known. Our objective was to determine regional and national prevalences of ADHD medication use in children and adults, with a specific focus on time trends in ADHD medication prevalence. METHODS: We did a retrospective, observational study using population-based databases from 13 countries and one Special Administrative Region (SAR): four in Asia and Australia, two in North America, five in northern Europe, and three in western Europe...
October 2018: Lancet Psychiatry
https://read.qxmd.com/read/30124189/adhd-science-stigma-and-service-implications
#20
B Gavin, F McNicholas
We are delighted to dedicate an edition of the Irish Journal of Psychological Medicine to the topic of attention-deficit hyperactivity disorder (ADHD). ADHD accounts for the majority of clinical presentations to Child and Adolescent Mental Health Services, both in terms of new assessments and ongoing attendances. Papers presented in this edition reflect on the evolving construct of ADHD, drawing from science, clinical practice and public opinion. Current and evidenced-based assessment and treatment practice guidelines are reviewed...
September 2018: Irish Journal of Psychological Medicine
keyword
keyword
171149
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"